Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.
Hengli ZhaoZhirui ZhaoKun HeNianrong MiKai LouXiaolin DongWenyu ZhangJingfang SunXinyu HuShuguang PangHong ChengQing WenPublished in: Clinical pharmacokinetics (2023)
China Drug Trial register ( http://www.chinadrugtrials.org.cn/I ) identifier no.: CTR20192721.